Although telomerase activity in hepatocellular carcinoma (HCC) increases in accordance with degree of histological undierentiation, it is unknown whether the level of telomerase activity in HCC re¯ects of the degree of activity in individual cells or the frequency of telomerasepositive HCC cells. Non-cancerous liver tissues exhibit low but signi®cant levels of telomerase activity, but the nature of telomerase-positive cells in these tissues is unclear. In this study, we performed immunohistochemical staining using speci®c antibody against telomerase reverse transcriptase (hTERT) protein in 15 HCC samples and 13 adjacent non-cancerous liver tissues. There were hTERT-positive hepatocytes, though very low frequency, in non-cancerous liver tissues. The frequencies in hTERT positive hepatocytes were very well correlated with clinicopathological parameters and telomerase activity levels: the average frequencies of chronic hepatitis was 0.2%, liver cirrhosis 0.2%, welldierentiated HCC 3.0%, moderately dierentiated HCC 28%, and poorly dierentiated HCC 95%. The intensity of staining varied among cells within a given specimen, and correlation with degree of histological undierentiation was less obvious. Portions of migrating lymphocytes and biliary epithelial cells were also hTERT-positive. These ®ndings indicate that the upregulation of telomerase activity with degree of undierentiation of HCC is mainly due to the increase in frequency of hTERT positive HCC cells. Oncogene (2000) 19, 3888 ± 3893.
Introduction
Telomeres are specialized structures at the ends of eukaryotic chromosomes and appear to function in chromosome stabilization, positioning, and replication (Blackburn et al., 1984; Zakian, 1989; Blackburn, 1991) . Telomeric DNA is shortened at each cell division. When the length of telomeric TTAGGG repeats is shortened, cells stop dividing. Normal human somatic cells correspondingly have a limited proliferative capacity. Telomerase, a reverse-transcriptive DNA polymerase that synthesizes telomere DNA to compensate for the loss of telomeric DNA that occurs at each cell division, plays a major role in maintaining telomere length and in inde®nite replicative life span (Blackburn, 1992; Counter et al., 1992; Harley et al., 1991) . Telomerase is expressed in most cancer cells and in a few types of somatic cells of cell renewal systems such as lymphocytes, intestinal mucosal cells, and skin basal cells, but not in the majority of somatic cells (Kim et al., 1994; Greider, 1998; Weng et al., 1998) . Generally, malignant tumors have strong telomerase activity, while the activity in surrounding non-cancerous lesions is weak or below detectable level. Thus, reactivation of telomerase represents an important step toward unlimited proliferation and inde®nite survival of cancer cells. We previously reported that hepatocellular carcinomas (HCC) exhibited a high incidence of telomerase activity and that telomerase activity increased in accordance with degree of histological undierentiation of HCC (Tahara et al., 1995; Nakashio et al., 1997) . The level of expression of hTERT mRNA determined by RT ± PCR was very well correlated, in both non-cancerous tissues and HCC tissues with telomerase activity level Takahashi et al., 2000) . Since these previous studies were based on the analyses in whole tissue extracts, it was unclear whether the level of telomerase activity observed re¯ected that in individual cells or the frequency in telomerase-positive cells. We also previously reported that such non-cancerous liver tissues as chronic hepatitis and liver cirrhosis exhibited low but signi®cant levels of telomerase activity (Tahara et al., 1995; Nakashio et al., 1997; Takaishi et al., 2000) . We did not know whether the low telomerase activity in these tissues was derived from hepatic cells or migrating lymphocytes. In situ detection of telomerase activity at the individual cell level could answer this question. However, the in situ TRAP method is very dicult, and has been applied only to limited specimens such as free cells or fresh-frozen tissues (Ohyashiki et al., 1997) . Immunostaining of hTERT protein can now be used as applicable for formalin®xed paran-embedded tissue sections. Recent in situ studies have revealed that hTERT protein is expressed only in cells and tissues positive for telomerase activity, i.e., tumor cells and such normal somatic cells as presumptive stem cells and progenitor cells in physiological cell renewal systems, and that hTERT protein is not detected in normal somatic cells that lack telomerase activity Yasui et al., 1999) . In the present study, it was clearly observed that the frequency of hTERT-positive cells was low in welldierentiated HCC and high in moderately or poorly dierentiated HCC, while no signi®cant dierence was found in variation in staining intensity among histologically dierent HCC cells. We also found, though at low frequency, hTERT-positive hepatocytes and biliary epithelial cells in non-cancerous liver tissues.
Results
Nuclei of poorly dierentiated HCC were stained with anti-hTERT antibody (Figure 1a ), but not with antibody pre-absorbed with hTERT peptide used as immunogen (Figure 1b) , indicating that positive signal in carcinoma cells was speci®c. Pre-immune antibody did not give positive staining (data not shown). Intensity of staining was not uniform among cells: some cells were stained strongly, but others weakly or not all (Figure 1a ). In addition, nuclei of moderately dierentiated HCC were stained with speci®c antibody against hTERT (Figure 2a ). The frequency of nuclei stained with the speci®c antibody was low in welldierentiated HCC (Figure 2b ). To obtain quantitative estimations of the expression of hTERT in HCC, we assessed hTERT-positive cells with respect to both frequencies in positive cells and intensity of the positive signal. The frequency in hTERT positive cells was determined by random evaluation of 500 ± 1000 cell nuclei in several microscopic ®elds. Clinicopathological parameters and frequencies of telomerase-positive hepatocytes are summarized in Table 1 . The frequency of hTERT-positive cells was very well correlated with clinicopathological parameters: CH (0.2%), LC (0.2%), well-dierentiated HCC (3.0%), moderately-dierentiated HCC (28%), and poorly-dierentiated HCC (95%). The frequency of hTERT-positive cells was well correlated, with a few exceptions among well-dierentiated HCCs, with telomerase activity level in tissue extracts (Figure 3 ), although not all samples used for immuno-histological examination were preserved for assay of telomerase activity. On the other hand, the signal intensity varied from weak to strong among HCC cells within a given specimen, as shown in Figures 1a and 2a . The signal intensity of hTERTpositive cells in the well-dierentiated HCC shown in Figure 2b was strong. Generally speaking, however, the more malignant the HCC, the more intensely was hTERT expressed at the individual cell level.
Non-cancerous tissues unexpectedly contained a signi®cant number of immuno-reactive hepatocytes ( Figure 4 ). Some in®ltrating lymphocytes were also stained (Figures 4 and 5d ). In addition to hepatocytes and lymphocytes, a signi®cant number of biliary epithelial cells were also moderately stained as shown in Figure 5 . The expression of hTERT was observed more frequently in biliary epithelial cells than in hepatocytes. Biliary cells were mainly stained in the nuclear periphery or nuclear membrane. Since signal disappeared following pre-absorption of antibody with hTERT peptide used as immunogen, staining was speci®c for hTERT protein ( Figure 5b ). As we have previously reported (Tahara et al., 1995; Nakashio et al., 1997) , chronic liver diseases such as chronic hepatitis and liver cirrhosis exhibited low but signi®cant levels of telomerase activity. We did not know at the time of publication of those reports whether the weak telomerase activity was derived from telomerasepositive hepatocytes or from in®ltrating lymphocytes. We now know that expression of hTERT protein was detected in hepatocytes in addition to lymphocytes and biliary epithelial cells.
Discussion
We have previously reported that HCCs exhibit a high incidence of telomerase activity, that non-cancerous liver tissues have feeble or no detectable activity, and that telomerase activity increases in accordance with degree of histological undierentiation of HCC (Tahara et al., 1995; Nakashio et al., 1997) . While the level of expression of hTERT mRNA and level of telomerase activity were not always well correlated in other tissues (Yasui et al., 1998 Ouellette et al., 1999; Nakamura et al., 1999) , they were well correlated in liver tissues, as we previously reported Takahashi et al., 2000) . It remained unclear, however, whether the increases in the level of telomerase activity with degree of histological undierentiation of HCC correlates with the increase in telomerase activity in individual carcinoma cells or with the increase in frequency of telomerase-positive carcinoma cells. In the present study, it was clearly observed that the frequency of hTERT-positive cells was correlated with the increase in telomerase activity level (Figure 3 ). Although the intensity of immunostaining in moderately or poorly dierentiated HCC was often higher than that in welldierentiated HCC or non-cancerous liver tissues, the signal intensity varied widely among cells even within one tissue sample, and the correlation between the signal intensity and degree of histological undierentiation was less obvious. These ®ndings indicated that the increase in telomerase activity level with degree of undierentiation of HCC was mainly due to the increase in frequency of hTERT-positive cells. In well-dierentiated HCC nodules, the majority of HCC cells were telomerase-negative and only a very small number of cells were telomerase-positive. This might be explained by two dierent ways. First, many, if not all, cells in an HCC nodule had the potential to express telomerase activity but were negative at the time of examination due to arrest of proliferation. Alternatively, all HCC cells in the nodule had progressed more malignant phenotype as diagnosed by cytological examination, but only a small portion of cells had an additional mutation resulting in expression of telomerase and had inde®nite proliferative capability. Since, that more malignant part of HCC sometimes arose as a`nodule-in nodule' within the less malignant part of a nodule, the latter explanation appears more likely, although it does not apply in all cases of HCC. We have previously reported that tissues of noncancerous liver diseases such as chronic hepatitis and liver cirrhosis exhibited low but signi®cant levels of telomerase activity (Tahara et al., 1995; Nakashio et al., 1997; Takaishi et al., 2000) . We did not know whether the low telomerase activity in these tissues was derived from precancerous immortalized hepatic cells or migrating lymphocytes. It was previously reported that hTERC was detected in chronic liver lesions by in situ staining, mainly in migrating lymphocytes and sinusoidal cells (Kolquist et al., 1998; Ogami et al., 1999) , but no report was published on in situ detection of hTERT in liver tissues. We found here that noncancerous liver tissues contained hTERT-positive hepatocytes, though at only 0.2% in frequency, in addition to hTERT-positive biliary epithelial cells and migrating lymphocytes. We do not know, however, whether the hTERT-positive hepatocytes in noncancerous tissues were precancerous immortalized cells or normal hepatic stem cells. Hepatocytes are usually in resting state in normal liver, following injury, however, they regenerate extensively. It was reported that proliferating hepatocytes were found mainly in periportal areas in chronic active hepatitis (Seki et al., 1990; Kawakita et al., 1992) . In experimental animals such as rats, oval cells arose in the periportal area of the liver after treatment with hepatocarcinogens or hepatotoxins, and these cells had the ability to proliferate and dierentiated into both mature hepatocytes and biliary epithelial cells (Dunsford et al., 1985 , Evarts et al., 1989; Elmore et al., 1991; Noviko et al., 1996; Golding et al., 1995) . The presence of oval cells in human liver has been reported, these cells proliferated in the periportal region and were suggested to be derived from a stem cell compartment (De Vos and Desmet, 1992; Haque et al., 1996; Demetris et al., 1996; Roskams et al., 1996; Ruck et al., 1996) . The largest number of stem cells was observed in the periportal region in fulminant hepatic failure (Baumann et al., 1999) . The hTERT-positive hepatocytes we reported here were mostly found at or around the periportal region, and they might be candidates for dormant stem (oval) cells. In this study, the expression of hTERT was also observed in biliary epithelial cells. Oval cells, presumptive stem cells, were found among biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis (Crosby et al., 1998a,b) and biliary epithelial cells were stained with antiDNA polimerase-a antibody (Seki et al., 1991) . The hTERTpositive biliary epithelial cells observed in our study might include epithelial stem cells and their progeny. It is unlikely that hTERT-positive biliary epithelial cells are precancerous immortal cells, since they are observed too frequently in non-cancerous tissues. However, the present observations do not provide direct evidence of, but are consistent with, the existence of a human hepatic stem cell. Determination whether such stem cells exist will require a speci®c marker of such cells.
Materials and methods

Samples
Specimens from 15 nodules of HCC were obtained from 13 patients who had undergone surgical resection at Hiroshima University Hospital and related facilities. Subsequently, samples from 13 adjacent non-cancerous liver tissues were also obtained as six chronic hepatitis and seven liver cirrhosis. Histologic grades of HCC were classi®ed into well, moderately, and poorly dierentiated HCC according to the Edmondson ± Steiner grading system (Edmondson & Steiner, 1954) . Of 15 HCC nodules, six were well-dierentiated, seven moderately dierentiated, and two poorly dierentiated (Table 1) . Of 13 HCC patients, two were positive for HBs antigen and 11 positive for HCV antibody. For immunohistochemistry, tissues were ®xed in 10% buer formalin and embedded in paran. To examine telomerase activity and expression of hTERT mRNA, tissues were frozen in liquid nitrogen immediately after removal and stored at 7808C.
Antibodies
A part of hTERT cDNA, corresponding to the nucleotide 1687 ± 2042 of the GenBank accession number AF015950 clone, was fused with the GST (glutathione S-transferase) gene, and the fused recombinant protein was produced in E. coli. The hTERT recombinant protein antibody (antihTERT1.0) was puri®ed by anity chromatography and used in this study. Validity of antibodies used here was discussed in the previous reports for Western blotting and immunostaining .
Immunohistochemical detection of hTERT protein
Immunohistochemical staining was performed as described previously (Yasui et al., 1998; Tahara et al., 1999) . In brief, three to ®ve micrometer-thick sections were prepared from paran blocks and deparanized with graded ethanol. Deparanized sections were immersed in methanol containing 0.03% hydrogen peroxide for 20 min to block the endogenous peroxidase activity. Microwave pretreatment in citrate buer was performed for 10 min three times to retrieve the antigenicity, and the sections were incubated with blocking solution for 10 min. The sections were treated at room temperature with anti-hTERT antibody (3 ± 5 mg/ml) for 90 min. The immuno-complex was visualized by a modi®cation of the immunoglobulin enzyme bridge technique (ABC method) using the SensiTek HRP kit (ScyTek Laboratories, Logan, UT, USA) (Yasui et al., 1996) . Since 3,3'-diaminobenzidine tetrahydrochloride was used as substrate, positive reaction was detected as a brown color. The sections were weakly counterstained with 0.1% hematoxylin. The speci®city of hTERT-immunostaining was determined by pre-absorption of the antibody with an excess of speci®c antigen.
Telomerase activity
Tissue samples were homogenized in CHAPS lysis buer (10 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 , 1 mM EDTA, 5 mM b-mercaptoethanol, 0.1 mM AEBSF (4-(2-aminoethyl)-bebzensulfonyl¯uoride hydrochlorine), 0.5% CHAPS (3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate), and 10% glycerol) (Kim et al., 1994) . After 20 min of incubation at 48C, the lysate was centrifuged at 16 000 g for 20 min at 48C. The supernatant was rapidly frozen and stored at 7808C . The protein concentration of the extract was measured using a DC protein kit (Bio-Rad, Hercules, California, USA). Telomerase activity was assayed by the TRAP (telomeric repeat ampli®cation protocol) assay with some modi®cations (Kim et al., 1994; Tahara et al., 1995; Nakashio et al., 1997) . In brief, an aliquot of extract containing 0.6 mg tissue protein was incubated with 20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 63 mM KCl, 1 mM EGTA, 0.005% Tween-20, 50 mM dNTPs, 0.1 mg of TS primer, 5 attogram of Internal Telomerase Assay Standard (ITAS) and 2 U of AmpliTaq DNA polymerases at 208C for 30 min. The reaction mixture was heat-inactivated at 908C for 3 min and 0.1 mg of CX primer was added. PCR (Polymerase chain reaction) was performed for 31 cycles at 948C for 45 s, 508C for 45 s and 728C for 90 s (2 min for ®nal step). PCR products of telomerase were analysed by electrophoresis on a 12% polyacrylamide gel. The gel was dried on ®lter paper and exposed to Fuji X-ray ®lm at 808C for 8 h with an intensifying screen. In some cases, the exposure period was extended up to 72 h. To estimate the levels of telomerase activity in tissue sample, we compared the intensity of the TRAP assay DNA ladder products with that of the ITAS signal using BioMax ID Software (Kodak, Rochester, NY, USA). Extract of a gastric-cancer cell line, MKN-1, was used as a positive control of telomerase activity (Nakashio et al., 1997) .
